Institute of Tendon and Bone Regeneration, Spinal Cord Injury and Tissue Regeneration, Center Salzburg, Paracelsus Medical University, Salzburg, Austria.
Center for Musculoskeletal Surgery, Campus Virchow, Charité Universitaetsmedizin, Berlin, Germany.
J Orthop Res. 2020 Jan;38(1):202-211. doi: 10.1002/jor.24473. Epub 2019 Oct 4.
MicroRNAs (miRNAs) have emerged as key regulators orchestrating a wide range of inflammatory and fibrotic diseases. However, the role of miRNAs in degenerative shoulder joint disorders is poorly understood. The aim of this explorative case-control study was to identify pathology-related, circulating miRNAs in patients with chronic rotator cuff tendinopathy and degenerative rotator cuff tears (RCT). In 2017, 15 patients were prospectively enrolled and assigned to three groups based on the diagnosed pathology: (i) no shoulder pathology, (ii) chronic rotator cuff tendinopathy, and (iii) degenerative RCTs. In total, 14 patients were included. Venous blood samples ("liquid biopsies") were collected from each patient and serum levels of 187 miRNAs were determined. Subsequently, the change in expression of nine candidate miRNAs was verified in tendon biopsy samples, collected from patients who underwent arthroscopic shoulder surgery between 2015 and 2018. Overall, we identified several miRNAs to be progressively deregulated in sera from patients with either chronic rotator cuff tendinopathy or degenerative RCTs. Importantly, for the several of these miRNAs candidates repression was also evident in tendon biopsies harvested from patients who were treated for a supraspinatus tendon tear. As similar expression profiles were determined for tendon samples, the newly identified systemic miRNA signature has potential as novel diagnostic or prognostic biomarkers for degenerative rotator cuff pathologies. © 2019 The Authors. Journal of Orthopaedic Research published by Wiley Periodicals, Inc. on behalf of Orthopaedic Research Society. Inc. J Orthop Res 38:202-211, 2020.
微小 RNA(miRNAs)已成为调节广泛的炎症和纤维化疾病的关键调控因子。然而,miRNAs 在退行性肩关节炎疾病中的作用尚未被充分了解。本探索性病例对照研究的目的是鉴定慢性肩袖肌腱病和退行性肩袖撕裂(RCT)患者中与病理相关的循环 miRNAs。2017 年,前瞻性纳入 15 例患者,并根据诊断病理学分为三组:(i)无肩部病理学,(ii)慢性肩袖肌腱病,和(iii)退行性 RCT。共纳入 14 例患者。采集每位患者的静脉血样本(“液体活检”),并测定 187 种 miRNA 的血清水平。随后,在 2015 年至 2018 年接受关节镜肩手术的患者的肌腱活检样本中验证了 9 种候选 miRNA 的表达变化。总体而言,我们发现几种 miRNA 在慢性肩袖肌腱病或退行性 RCT 患者的血清中逐渐失调。重要的是,对于其中几种候选 miRNA,在接受治疗的冈上肌腱撕裂患者的肌腱活检中也明显受到抑制。由于肌腱样本的表达谱相似,新确定的系统 miRNA 特征有可能成为退行性肩袖病变的新型诊断或预后生物标志物。©2019 作者。 Wiley Periodicals, Inc. 代表骨科研究协会出版的《骨科研究杂志》。J Orthop Res 38:202-211,2020 年。